COLL NASDAQ
Collegium Pharmaceutical, Inc.
1W: -2.3%
1M: -9.4%
3M: -41.2%
YTD: -51.6%
1Y: -37.4%
3Y: -1.5%
5Y: +7.7%
$22.02
+0.18 (+0.82%)
Weekly Expected Move ±3.3%
$21
$21
$22
$23
$23
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
4 relationships4
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2022-02-14
Earliest Filing
2024-09-04
Latest Filing
target: 3
acquirer: 1
Counterparties (Filed by COLL)
4 relationshipsCompanies named in COLL's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Ironshore Therapeutics Inc. | — | target | Target company in the merger agreement acquired by Collegium Pharmaceutical, Inc. | 2024-09-04 | View |
| Ironshore Therapeutics Inc. | — | target | Target company in the merger agreement with Collegium Pharmaceutical, Inc. | 2024-07-29 | View |
| Bristol Acquisition Company Inc. | — | acquirer | Wholly owned subsidiary of Collegium that entered into a Merger Agreement to conduct a cash tender offer for BDSI. | 2022-02-14 | View |
| BioDelivery Sciences International, Inc. | BDSI | target | Target company whose common stock is the subject of the cash tender offer and subsequent merger. | 2022-02-14 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-13 | Other Events | View | |
| 2026-08-06 | Earnings Release; Regulation FD | View | |
| 2026-06-30 | Exhibits | View | |
| 2026-05-15 | Shareholder Vote | View | |
| 2026-05-12 | Acquisition/Disposition; Officer/Director Change; Regulation FD; Exhibits | Acquisition | View |
| 2026-05-07 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-04-07 | Officer/Director Change | View | |
| 2026-02-26 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-08 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-12-30 | Entry into Material Definitive Agreement; Termination of Material Definitive Agreement; Unregistered | Agreement | View |
| 2025-11-06 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-08-07 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-07-07 | Other Events | View | |
| 2025-05-19 | Departure/Election of Directors; Appointment of Officers; Submission of Matters to a Vote of Securit | View | |
| 2025-05-12 | Other Events | View | |
| 2025-05-08 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-03-17 | Departure/Election of Directors; Appointment of Officers; Other Events | View | |
| 2025-02-27 | Results of Operations and Financial Condition; Departure/Election of Directors; Appointment of Offic | View | |
| 2025-02-05 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-01-08 | Regulation FD Disclosure; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR